The company's stock has come under pressure following March-in requests from U.S. representatives in an open letter to the National Institutes of Health. INTEREST FROM POTENTIAL BUYERS: Medivation is working with advisers to defend against a potential takeover after receiving preliminary interest from possible buyers, Bloomberg reported yesterday, citing people familiar with the matter.